|
WWP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.85183029705649E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
4.767800E-01 |
| Stage1-vs-Stage3 |
1.304800E-01 |
| Stage1-vs-Stage4 |
2.984300E-02 |
| Stage2-vs-Stage3 |
1.091610E-01 |
| Stage2-vs-Stage4 |
2.505800E-02 |
| Stage3-vs-Stage4 |
3.610600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
2.23130003362826E-09 |
| Normal-vs-Asian |
1.78135284301106E-12 |
| Caucasian-vs-AfricanAmerican |
2.983800E-01 |
| Caucasian-vs-Asian |
4.685000E-01 |
| AfricanAmerican-vs-Asian |
6.793400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.143000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.95814999999211E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.189400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.544200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.978800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.145600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.905000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.166200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.279600E-01 |
| Classical-VS-Follicular |
4.478800E-01 |
| Classical-VS-Other |
7.530200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.040790E-01 |
| Tall-VS-Other |
3.743400E-01 |
| Tall-VS-Normal |
1.83342230286598E-12 |
| Follicular-VS-Other |
9.824800E-01 |
| Follicular-VS-Normal |
1.65512048511118E-12 |
| Other-VS-Normal |
3.414800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
4.982000E-02 |
|
|
